Incannex Healthcare Limited (NASDAQ: $IXHL ) (ASX: IHL), ('Incannex' or the 'Company'
a clinical stage pharmaceutical development company, is pleased to provide its quarterly activities report and appendix 4C for the period ended 31st March 2022. https://finance.yahoo.com/news/quarterly-acti...00025.html
a clinical stage pharmaceutical development company, is pleased to provide its quarterly activities report and appendix 4C for the period ended 31st March 2022. https://finance.yahoo.com/news/quarterly-acti...00025.html